DWM
VCYT icon

DeLarme Wealth Management’s Veracyte VCYT Stock Holding History

DeLarme Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
+5,000
New +$210K 0.17% 53
2026
Q1 		– Sell
-6,000
Closed -$253K – 66
2025
Q4 		$253K Buy
+6,000
New +$242K 0.18% 53

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DeLarme Wealth Management's VCYT Position: Q2 2026 in Review

DeLarme Wealth Management opened a new position in Veracyte (VCYT) in Q2 2026: 5,000 shares worth $294K. The stake represents 0.17% of the portfolio and ranks #53 among its holdings. This is a return to the name: DeLarme Wealth Management previously reported a position in VCYT as recently as Q4 2025.

DeLarme Wealth Management first reported a position in VCYT in Q4 2025 and has held it in 2 quarters since. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • DeLarme Wealth Management held 5,000 shares of Veracyte worth $294K as of Q2 2026.
  • Veracyte was a new DeLarme Wealth Management position in Q2 2026.
  • Veracyte made up 0.17% of DeLarme Wealth Management's portfolio in Q2 2026, its #53 holding.
  • DeLarme Wealth Management first reported a position in Veracyte in Q4 2025 and has held it in 2 quarters since.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on DeLarme Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.